March 23, 2020 / 8:48 AM / 6 days ago

BRIEF-Creo Medical Receives Clearance From U.S. FDA For Hs1 Haemostasis Device

March 23 (Reuters) - Creo Medical Group PLC:

* CREO MEDICAL GROUP - RECEIVED CLEARANCE FROM U.S. FDA FOR HS1 HAEMOSTASIS DEVICE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below